Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorColomer Castell, Sergi
dc.contributor.authorGonzález Sánchez, Alejandra
dc.contributor.authorCampos Martinez, Carolina
dc.contributor.authorGarcia Cehic, Damir
dc.contributor.authorAndrés Verges, Cristina
dc.contributor.authorPiñana Moro, Maria
dc.contributor.authorPumarola Suñé, Tomàs
dc.contributor.authorRodríguez Frias, Francisco
dc.contributor.authorAntón Pagarolas, Andres
dc.contributor.authorQuer Sivila, Josep
dc.contributor.authorGregori Font, Josep
dc.contributor.authorIbañez Lligoña, Marta
dc.date.accessioned2023-03-21T09:16:13Z
dc.date.available2023-03-21T09:16:13Z
dc.date.issued2023-02-20
dc.identifier.citationIbañez-Lligoña M, Colomer-Castell S, González-Sánchez A, Gregori J, Campos C, Garcia-Cehic D, et al. Bioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses. Viruses. 2023 Feb 20;15(2):587.
dc.identifier.issn1999-4915
dc.identifier.urihttps://hdl.handle.net/11351/9210
dc.descriptionDiagnostic tools; Metagenomics; Viruses
dc.description.abstractEpidemics and pandemics have occurred since the beginning of time, resulting in millions of deaths. Many such disease outbreaks are caused by viruses. Some viruses, particularly RNA viruses, are characterized by their high genetic variability, and this can affect certain phenotypic features: tropism, antigenicity, and susceptibility to antiviral drugs, vaccines, and the host immune response. The best strategy to face the emergence of new infectious genomes is prompt identification. However, currently available diagnostic tests are often limited for detecting new agents. High-throughput next-generation sequencing technologies based on metagenomics may be the solution to detect new infectious genomes and properly diagnose certain diseases. Metagenomic techniques enable the identification and characterization of disease-causing agents, but they require a large amount of genetic material and involve complex bioinformatic analyses. A wide variety of analytical tools can be used in the quality control and pre-processing of metagenomic data, filtering of untargeted sequences, assembly and quality control of reads, and taxonomic profiling of sequences to identify new viruses and ones that have been sequenced and uploaded to dedicated databases. Although there have been huge advances in the field of metagenomics, there is still a lack of consensus about which of the various approaches should be used for specific data analysis tasks. In this review, we provide some background on the study of viral infections, describe the contribution of metagenomics to this field, and place special emphasis on the bioinformatic tools (with their capabilities and limitations) available for use in metagenomic analyses of viral pathogens.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesViruses;15(2)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectGenòmica
dc.subjectGenètica vírica
dc.subjectEpidèmies
dc.subjectBiologia computacional
dc.subject.meshMetagenomics
dc.subject.meshComputational Biology
dc.subject.meshPandemics
dc.subject.meshViruses
dc.titleBioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/v15020587
dc.subject.decsmetagenómica
dc.subject.decsbiología computacional
dc.subject.decspandemias
dc.subject.decsvirus
dc.relation.publishversionhttps://doi.org/10.3390/v15020587
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Ibañez-Lligoña M, Colomer-Castell S, Campos C, Quer J] Grup de Recerca de Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. [González-Sánchez A, Andrés C, Piñana M] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Gregori J] Grup de Recerca de Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Garcia-Cehic D] Grup de Recerca de Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. [Pumarola T, Antón A] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rodríguez-Frias F] Grup de Recerca de Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain
dc.identifier.pmid36851800
dc.identifier.wos000940038600001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0016%2F0003
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00301
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record